Scientists are increasingly focused on retatrutide, a innovative treatment developed by Eli Lilly, as a possible breakthrough in body loss . Unlike many previous approaches, retatrutide is a dual -action compound targeting equally GLP-1 and GIP, hormones that influence appetite and glucose control